SCHEMBL16152246

SCHEMBL16152246

CC(C)(C)OC(=O)NCCCNC(=O)c1cccc(C(=O)NCCCNC(=O)OC(C)(C)C)c1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.60
TP53BP1 Q12888 4/20 0.56
TDP1 Q9NUW8 2/20 0.50
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
KMT2A Q03164 3/20 0.48
MEN1 O00255 2/20 0.48
GAA P10253 3/20 0.48
NQO2 P16083 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
HSD17B10 Q99714 1/20 0.46
MAPT P10636 1/20 0.46
CA12 O43570 1/20 0.46
CA9 Q16790 1/20 0.46
ALDH1A1 P00352 1/20 0.46
POLB P06746 1/20 0.46
ACACB O00763 1/20 0.46
ACACA Q13085 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL284884 0.96 SMN1; SMN2 (0.59) SMN1; SMN2TP53BP1TDP1CA1CA2
SCHEMBL16151786 0.95 SMN1; SMN2 (0.71) SMN1; SMN2TP53BP1TDP1CA1CA2
SCHEMBL284764 0.94 SMN1; SMN2 (0.55) SMN1; SMN2TP53BP1KMT2AMEN1GAA
SCHEMBL14679385 0.92 NPC1 (0.54) SMN1; SMN2TP53BP1KMT2AMEN1GAA
SCHEMBL22767691 0.91 TDP1 (0.56) SMN1; SMN2TDP1CA1CA2KMT2A
SCHEMBL31407324 0.91 TP53BP1 (0.70) SMN1; SMN2TP53BP1KMT2AMEN1L3MBTL1
SCHEMBL1467340 0.90 NAAA (0.56) SMN1; SMN2TDP1KMT2AMEN1GAA
SCHEMBL14679384 0.89 NPC1 (0.54) SMN1; SMN2TP53BP1TDP1KMT2AMEN1
SCHEMBL5663889 0.89 SMN1; SMN2 (0.50) SMN1; SMN2TP53BP1CA1CA2KMT2A
SCHEMBL264483 0.89 SMN1; SMN2 (0.50) SMN1; SMN2TP53BP1KMT2AMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10440955-B2 Methods comprising a biocidal polyamine CURZA GLOBAL, LLC (US) 2019-10-15 US disclosed
US-20180125070-A1 COMPOSITIONS AND METHODS COMPRISING A BIOCIDAL POLYAMINE THE UNIVERSITY OF UTAH 2018-05-10 US disclosed
US-9839219-B2 Compositions comprising a biocidal polyamine CURZA GLOBAL, LLC (US) 2017-12-12 US disclosed
US-20160330962-A1 COMPOSITIONS COMPRISING A BIOCIDAL POLYAMINE CURZA GLOBAL, LLC 2016-11-17 US disclosed
US-9439433-B2 Compositions and methods comprising a biocidal polyamine CURZA GLOBAL, LLC (US) 2016-09-13 US disclosed
US-9220267-B2 Methods of use comprising a biocidal polyamine CURZA GLOBAL, LLC (US) 2015-12-29 US disclosed
US-20150274639-A1 METHODS OF USE FOR COMPOSITIONS COMPRISING A BIOCIDAL POLYAMINE CURZA GLOBAL, LLC 2015-10-01 US disclosed
US-9034927-B2 Methods of use for compositions comprising a biocidal polyamine CURZA GLOBAL, LLC (US) 2015-05-19 US disclosed
US-20150038705-A1 METHODS OF USE COMPRISING A BIOCIDAL POLYAMINE CURZA GLOBAL, LLC 2015-02-05 US disclosed
US-20150038512-A1 COMPOSITIONS AND METHODS COMPRISING A BIOCIDAL POLYAMINE THE UNIVERSITY OF UTAH 2015-02-05 US disclosed
US-20140350017-A1 METHODS OF USE FOR COMPOSITIONS COMPRISING A BIOCIDAL POLYAMINE THE UNIVERSITY OF UTAH (US) 2014-11-27 US disclosed
US-8853278-B1 Compositions comprising a biocidal polyamine CURZA GLOBAL, LLC (US) 2014-10-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140350017-A1 METHODS OF USE FOR COMPOSITIONS COMPRISING A BIOCIDAL POLYAMINE SRM, SMOX, SMS SMN1; SMN2 4707/4885TP53BP1 2042/4885TDP1 440/4885
US-20150038705-A1 METHODS OF USE COMPRISING A BIOCIDAL POLYAMINE SRM, SMOX, SMS SMN1; SMN2 4706/4885TP53BP1 2232/4885TDP1 532/4885
US-20160330962-A1 COMPOSITIONS COMPRISING A BIOCIDAL POLYAMINE SRM, SMS, SMOX SMN1; SMN2 4729/4885TP53BP1 1458/4885TDP1 367/4885
US-10440955-B2 Methods comprising a biocidal polyamine SRM, SMOX, SMS SMN1; SMN2 4734/4885TP53BP1 1811/4885TDP1 419/4885
US-20180125070-A1 COMPOSITIONS AND METHODS COMPRISING A BIOCIDAL POLYAMINE SRM, SMOX, SMS SMN1; SMN2 4731/4885TP53BP1 1832/4885TDP1 450/4885
US-20150038512-A1 COMPOSITIONS AND METHODS COMPRISING A BIOCIDAL POLYAMINE SRM, SMOX, SMS SMN1; SMN2 4731/4885TP53BP1 1832/4885TDP1 450/4885
US-20150274639-A1 METHODS OF USE FOR COMPOSITIONS COMPRISING A BIOCIDAL POLYAMINE SRM, SMOX, SMS SMN1; SMN2 4707/4885TP53BP1 2042/4885TDP1 440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.